Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign hae...
Saved in:
Main Authors: | Usman Hammawa Malabu, Rozemary Karamatic, Gillian Mahy, Kunwarjit Singh Sangla |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2011/342480 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Incidentaloma to Suspicion of Malignancy: The Diverse Clinical Presentation of Gonadal Schistosomiasis mansoni
by: Laiana do Carmo Almeida, et al.
Published: (2013-01-01) -
CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01) -
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01) -
Proton Pump Inhibitors: How Appropriate?
by: Daniel C Sadowski
Published: (2000-01-01)